RUNNING SYSTEM CHECKSystem-check-btn-loading
About This Webinar
The correct quantification of intact AAV capsids is a prerequisite for safe and effective gene transfer. As the exclusive manufacturer of AAV antibodies and established AAV quantification ELISAs, PROGEN provides high-quality tools for gene therapy. Explore our digital booth to learn how our calibrated ELISAs measure accurate titers of the most commonly used AAV serotype capsids and how you can save time with the 2 hrs Xpress version. Check our posters, presentations and videos on latest advancements in AAV titer determination, standardization, or cell-based neutralization assays!

Get in touch with us any time during the conference and afterwards (info@progen.com)!

Agenda
  • Tuesday May 12, 4.15 - 4.30 pm: Tools & Technologies Forum Presentation "AAV Antibodies - Overview of Qualified Applications" by Dana Holzinger, Product Manager
  • Wednesday May 13, 5.30 - 6.30 pm: Poster Presentation #901 "AAV capsid antibodies as positive control for neutralization assays"
  • Thursday May 14, 5.30 - 6.30 pm: Poster Presentation #1295 "AAV Xpress ELISA - finish it faster"
Presenters
  • 1589013806-479d4bb61b5137a4
    Caroline Odenwald
    Marketing Communications Manager
    Marketing Communications Manager since 2018. Caroline is responsible for the conception, planning and implementation of PROGEN´s marketing activities (e.g. articels, application notes & online marketing)
  • 1589013877-0562a3603a157d8f
    Dana Holzinger
    Product Manager
    Product Manager since 2019. Dana represents the interface between the in-house R&D and customer needs for the AAV Titration ELISAs and AAV antibodies.
  • 1588777104-2e7eca200c1979e4
    Isabelle Hinner
    Strategic Account Manager
    Strategic Account Manager since 2019.
    Isabelle is responsible for the establishment and maintenance of PROGEN´s international customer relationships, the cooperation with distributors and the identification of the customer requirements.
  • 1589013943-8fe7f95470e4aa1e
    Katharina Hammer
    Director Quality Control
    Director Quality Control since 2016. Katharina is responsible for all quality relevant steps concerning the AAV ELISAs and is strongly involved in AAV analytics.
  • 1589013751-b582cb2c9777bdc4
    Ina Berger
    Scientific Support Representative
    Scientific Support Representative since 2016. Ina provides high-level technical support concerning all product-related question. As a biological PhD she possesses hands-on experience in the lab.
  • 1589014013-aec6c123cc6ffb37
    Katja Betts
    CEO
    CEO since 2019. Katja is a keen networker and always interested in setting up mutually beneficial collaborations that further the field of AAV gene therapy.
  • 1588944434-058c38fc42af52ad
    Hüseyin Besir
    Director Research & Development
    Director R&D since 2016
    Hüseyin is responsible for developing new and reliable products as well as evaluating new technologies and tools for expanding PROGEN’s AAV portfolio.
Powered by BigMarker